Companies To Watch
-
Companies To Watch: Akero Therapeutics
2/1/2021
Companies To Watch: Akero Therapeutics - Test-proofing a new metabolism drug to beat the liver disease, NASH
-
Companies To Watch: Artax Biopharma
1/4/2021
Artax Biopharma is challenging the immunosuppressive paradigm with a novel drug for autoimmune diseases.
-
Companies To Watch: Ridgeback Biotherapeutics
10/30/2020
Ridgeback Biotherapeutics is pitting new and potent antivirals versus COVID, Ebola, and other coronaviruses.
-
Companies To Watch: Osivax
10/1/2020
Osivax is developing universal vaccines for influenza, coronaviruses, and other infectious diseases such as malaria and human papillomavirus (HPV). Preclinical studies also have started on a coronavirus vaccine, which would include Covid-19.
-
Companies To Watch: CalciMedica
9/1/2020
“In a sense, the Covid association was a golden opportunity for our drug,” says Rachel Leheny, CEO of CalciMedica, a pharma focused on anti-inflammatories for pancreatitis that has now shifted to treatments for Covid-19 pneumonia.
-
Companies To Watch: Cidara Therapeutics
8/3/2020
Cidara Therapeutics is training its novel treatment and preventative for flu and other viral infections on Covid-19.
-
Companies To Watch: Equillium
7/1/2020
Equillium is keeping a close eye on the COVID-19 challenge, but sticking to acute GVHD, uncontrolled asthma, and lupus nephritis as primary inflammation targets.
-
Companies To Watch: Spring Bank Pharmaceuticals
6/1/2020
Spring Bank Pharmaceuticals is continuing clinical programs during the COVID-19 challenge and advancing novel approaches to cancer, inflammation, and viruses.
-
Companies To Watch: argenx
5/1/2020
Argenx is developing new antibody therapeutics for immunological diseases in the neuromuscular, hematology, oncology, and other areas. The company has a full pipeline of candidates and indications.
-
Companies To Watch: Neurana
4/1/2020
This 10-person startup in San Diego is aiming for muscle-spasm relief without sedation in a purified drug.